Natural Capsules Limited — Investor Meet, 10-06-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Natural Capsules has announced a board meeting to consider the financial results for the quarter and half-year.

Q4 revenue rose 2.6% QoQ to Rs. 44.97 Cr, with EBITDA up 2.7% to Rs. 4.38 Cr (9.7% margin). PAT jumped 393% QoQ to Rs. 0.52 Cr but fell 46% YoY. FY’25 revenue grew 8.9% to Rs. 169.21 Cr; EBITDA declined 12% to Rs. 17.52 Cr with margin down 250 bps, while PAT dropped 89% to Rs. 0.62 Cr. HPMC capsules show strong export potential due to US duty advantage, targeting Rs. 27 Cr revenue in FY’26 and 14-15% margins. API segment faces pricing pressures but expects regulatory approvals by FY’26-end/FY’27, with ramp-up from Q2 FY’26. Group revenue guidance near Rs. 260 Cr. Management emphasizes export growth, margin expansion, and breakeven in API operations, remaining cautiously optimistic.